Literature DB >> 24898063

Self-assembled nanoparticles as multifunctional drugs for anti-microbial therapies.

Manpreet Bhatti1, Timothy D McHugh, Lilia Milanesi, Salvador Tomas.   

Abstract

A self-assembled nanoparticle containing a photosensitizer and a Trojan-horse moiety (cholesterol), binds an anti-TB pro-drug and increases 1000-fold its activity against mycobacteria. These minimalist constructs will allow development of economically viable, efficient drug preparations for the treatment of drug-resistant TB infections.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24898063     DOI: 10.1039/c4cc00349g

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  5 in total

Review 1.  Photoinactivation of mycobacteria to combat infection diseases: current state and perspectives.

Authors:  Margarita Shleeva; Alexander Savitsky; Arseny Kaprelyants
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-17       Impact factor: 4.813

2.  Water-soluble benzylidene cyclopentanone based photosensitizers for in vitro and in vivo antimicrobial photodynamic therapy.

Authors:  Yanyan Fang; Tianlong Liu; Qianli Zou; Yuxia Zhao; Feipeng Wu
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

3.  A nuclear targeted dual-photosensitizer for drug-resistant cancer therapy with NIR activated multiple ROS.

Authors:  Zhengze Yu; Wei Pan; Na Li; Bo Tang
Journal:  Chem Sci       Date:  2016-03-11       Impact factor: 9.825

Review 4.  Self-Assembled Antimicrobial Nanomaterials.

Authors:  Ana Maria Carmona-Ribeiro
Journal:  Int J Environ Res Public Health       Date:  2018-07-04       Impact factor: 3.390

5.  OBP-functionalized/hybrid superparamagnetic nanoparticles for Candida albicans treatment.

Authors:  Nicolò Riboni; Costanza Spadini; Clotilde S Cabassi; Federica Bianchi; Stefano Grolli; Virna Conti; Roberto Ramoni; Francesca Casoli; Lucia Nasi; César de Julián Fernández; Paola Luches; Maria Careri
Journal:  RSC Adv       Date:  2021-03-17       Impact factor: 3.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.